Notably, synovial fibroblasts were recently shown to drive the local inflammatory tissue priming in preclinical models of arthritis in a C3-dependent manner; the primed fibroblast appeared to upregulate both C3 and CXCL14 mRNA expression.71 The gene discussed is CXCL14; the disease is arthritic joint disease.